Diffuse Large B-Cell Lymphoma’s New Genomics: The Bridge and the Chasm

por Crombie, Jennifer L., Armand, Philippe
Publicado 2020

Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?

por Houot, Roch, Levy, Ronald, Cartron, Guillaume, Armand, Philippe
Publicado 2020

Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?

por Chiappella, Annalisa, Crombie, Jennifer, Guidetti, Anna, Vitolo, Umberto, Armand, Philippe, Corradini, Paolo
Publicado 2019

Refractory myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high throughput somatic sequencing

por Mandelker, Diana, Dal Cin, Paola, Jacene, Heather A., Armand, Philippe, Stone, Richard M., Lindeman, Neal I.
Publicado 2015

Multicenter Validation Study of a Transplantation-Specific Cytogenetics Grouping Scheme for Patients with Myelodysplastic Syndromes

por Armand, Philippe, Deeg, H. Joachim, Kim, Haesook T., Lee, Hun, Armistead, Paul, de Lima, Marcos, Gupta, Vikas, Soiffer, Robert J.
Publicado 2009

A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies

por Armand, Philippe, Lesokhin, Alexander, Borrello, Ivan, Timmerman, John, Gutierrez, Martin, Zhu, Lili, Popa McKiver, Mihaela, Ansell, Stephen M.
Publicado 2020

The Incidence of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

por Hwang, Jisun, Suh, Chong Hyun, Won Kim, Kyung, Kim, Ho Sung, Armand, Philippe, Huang, Raymond Y., Guenette, Jeffrey P.
Publicado 2021

Real‐World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B‐Cell Lymphoma in the U.S

por Yang, Xiaoqin, Laliberté, François, Germain, Guillaume, Raut, Monika, Duh, Mei Sheng, Sen, Shuvayu S., Lejeune, Dominique, Desai, Kaushal, Armand, Philippe
Publicado 2021

P1067: ESTIMATING THE RELATIVE EFFICACY OF FAVEZELIMAB WHEN USED IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH PD-1–REFRACTORY CLASSICAL HODGKIN LYMPHOMA

por Armand, Philippe, Luigi Zinzani, Pier, Timmerman, John, Johnson, Nathalie, Lavie, David, Thiagarajan, Kannan, Topp, Brian, Pillai, Pallavi, Herrera, Alex F.
Publicado 2023

Venous thromboembolism is associated with graft-versus-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation

por Kekre, Natasha, Kim, Haesook T., Ho, Vincent T., Cutler, Corey, Armand, Philippe, Nikiforow, Sarah, Alyea, Edwin P., Soiffer, Robert J., Antin, Joseph H., Connors, Jean M., Koreth, John
Publicado 2017

A phase 1b/2 study of duvelisib in combination with FCR (DFCR) for frontline therapy for younger CLL patients

por Davids, Matthew S., Fisher, David C., Tyekucheva, Svitlana, McDonough, Mikaela, Hanna, John, Lee, Brandon, Francoeur, Karen, Montegaard, Josie, Odejide, Oreofe, Armand, Philippe, Arnason, Jon, Brown, Jennifer R.
Publicado 2020

Long-Term Follow-up of Reduced Intensity Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia: Prognostic Model to Predict Outcome

por Brown, Jennifer R., Kim, Haesook T., Armand, Philippe, Cutler, Corey, Fisher, David C., Ho, Vincent, Koreth, John, Ritz, Jerome, Wu, Catherine, Antin, Joseph H., Soiffer, Robert J., Gribben, John G., Alyea, Edwin P.
Publicado 2012

Pembrolizumab in relapsed or refractory Richter syndrome

por Armand, Philippe, Murawski, Niels, Molin, Daniel, Zain, Jasmine, Eichhorst, Barbara, Gulbas, Zafer, Hawkes, Eliza A., Pagel, John M., Phillips, Tycel, Ribrag, Vincent, Svoboda, Jakub, Stathis, Anastasios, Chatterjee, Arkendu, Orlowski, Robert, Marinello, Patricia, Christian, Beth
Publicado 2020

Brentuximab vedotin plus doxorubicin and dacarbazine in nonbulky limited-stage classical Hodgkin lymphoma

por Abramson, Jeremy S., Bengston, Elizabeth, Redd, Robert, Barnes, Jeffrey A., Takvorian, Tak, Sokol, Lubomir, Lansigan, Frederick, Armand, Philippe, Shah, Bijal, Jacobsen, Eric, Martignetti, Rosalba, Turba, Elyce, Metzler, Sara, Patterson, Victoria, LaCasce, Ann S., Bello, Celeste M.
Publicado 2022

P1065: UPDATED RESULTS FROM AN OPEN-LABEL PHASE 1/2 STUDY OF FAVEZELIMAB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANTI–PD-1–NAIVE RELAPSED OR REFRACTORY CLASSICAL HODGKIN...

por Johnson, Nathalie, Lavie, David, Borchmann, Peter, Gregory, Gareth, Herrera, Alex F., Minuk, Leonard, Vucinic, Vladan, Armand, Philippe, Avigdor, Abraham, Gasiorowski, Robin, Herishanu, Yair, Keane, Colm, Kuruvilla, John, Marceau West, Rachel, Pillai, Pallavi, Marinello, Patricia, Timmerman, John
Publicado 2023

586. Immunogenicity of COVID-19 mRNA Vaccines in Patients with Lymphoid Malignancies

por Izaguirre, Natalie E, Sherman, Amy C, Crombie, Jennifer, Desjardins, Michaël, Cheng, Chi-An, Gilboa, Tal, Powell, Megan, Bausk, Bruce P, Abasciano, Noah, Baker, Peter, McDonough, Mikaela, Armand, Philippe, Walt, David, Issa, Nicolas C, Baden, Lindsey R
Publicado 2021

P061: Safety and Dose-Expansion Study of Combination Favezelimab (anti–LAG-3) Plus Pembrolizumab in Anti–PD-1–Naive Patients With Relapsed or Refractory Classical Hodgkin Lymphoma...

por Borchmann, Peter, Johnson, Nathalie A., Lavie, David, Gregory, Gareth, Herrera, Alex F., Minuk, Leonard, Vucinic, Vladan, Armand, Philippe, Avigdor, Abraham, Gasiorowski, Robin, Herishanu, Yair, Keane, Colm, Kuruvilla, John, Palcza, John, Pillai, Pallavi, Nahar, Akash, Timmerman, John
Publicado 2022

Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy

por Crombie, Jennifer L., Jacobson, Caron A., Redd, Robert, Shouse, Geoffrey, Herrera, Alex F., Chow, Victor A., Gauthier, Jordan, Mullane, Erin, Cahill, Kirk, Kline, Justin, Romancik, Jason, Cohen, Jonathon B., Saucier, Anna, Houot, Roch, Armand, Philippe, Hess, Brian
Publicado 2023

Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors

por Gadi, Deepti, Martindale, Stephen P., Chiu, Pui Yan, Khalsa, Jasneet, Chen, Pei-Hsuan, Fernandes, Stacey M., Wang, Zixu, Tyekucheva, Svitlana, Machado, John-Hanson, Fisher, David C., Armand, Philippe, Davids, Matthew S., Rodig, Scott, Sherry, Barbara, Brown, Jennifer R.
Publicado 2023

Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses

por Bu, Xia, Juneja, Vikram R., Reynolds, Carol G., Mahoney, Kathleen M., Bu, Melissa T., McGuire, Kathleen A., Maleri, Seth, Hua, Ping, Zhu, Baogong, Klein, Sarah R., Greenfield, Edward A., Armand, Philippe, Ritz, Jerome, Sharpe, Arlene H., Freeman, Gordon J.
Publicado 2021